Ataxin-2 as potential disease modifier in C90RF72 expansion carriers (2014)
Fonte: Neurobiology of aging. Unidade: FM
Assuntos: MUTAÇÃO GENÉTICA, DOENÇAS (METABOLISMO), NEURÔNIOS MOTORES (PATOLOGIA)
ABNT
BLITTERSWIJK, Marka van et al. Ataxin-2 as potential disease modifier in C90RF72 expansion carriers. Neurobiology of aging, v. 35, n. 3, p. 2421e13-2421e17, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.neurobiolaging.2014.04.016. Acesso em: 21 out. 2025.APA
Blitterswijk, M. van, Mullen Bianca,, Heckman, M., Grinberg, L. T., Backer, M., Hernandez, M. de J., et al. (2014). Ataxin-2 as potential disease modifier in C90RF72 expansion carriers. Neurobiology of aging, 35( 3), 2421e13-2421e17. doi:10.1016/j.neurobiolaging.2014.04.016NLM
Blitterswijk M van, Mullen Bianca, Heckman M, Grinberg LT, Backer M, Hernandez M de J, Brown P, Murray M, Hsiung GY, Stewart H, Karydas A, Finger E, Kertesz A, Bigio E, Weintraub S, Mesulam M, Hatanpaa K, White III C, Neumann M, Strong M, Beach T, Wszolek Z, Lippa C, Caselli R, Petrucelli L, Josephs K, Parisi J, Knopman D, Peterson R, Mackenzie I, Seeley william, Miller B, Boylan K, Graff-Radford N, Boeve BF, Dickson D, Rademarkers R. Ataxin-2 as potential disease modifier in C90RF72 expansion carriers [Internet]. Neurobiology of aging. 2014 ; 35( 3): 2421e13-2421e17.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.neurobiolaging.2014.04.016Vancouver
Blitterswijk M van, Mullen Bianca, Heckman M, Grinberg LT, Backer M, Hernandez M de J, Brown P, Murray M, Hsiung GY, Stewart H, Karydas A, Finger E, Kertesz A, Bigio E, Weintraub S, Mesulam M, Hatanpaa K, White III C, Neumann M, Strong M, Beach T, Wszolek Z, Lippa C, Caselli R, Petrucelli L, Josephs K, Parisi J, Knopman D, Peterson R, Mackenzie I, Seeley william, Miller B, Boylan K, Graff-Radford N, Boeve BF, Dickson D, Rademarkers R. Ataxin-2 as potential disease modifier in C90RF72 expansion carriers [Internet]. Neurobiology of aging. 2014 ; 35( 3): 2421e13-2421e17.[citado 2025 out. 21 ] Available from: https://doi.org/10.1016/j.neurobiolaging.2014.04.016